Baker Hughes Company (BKR) Financials

BKR

Trailing 12 months to June 30, 2026

Revenue $27.7B +0.4% YoY

Net Income $3.1B +1.6% YoY

Free Cash Flow $3.1B +44.5% YoY

Operating Cash Flow $4.4B +29.7% YoY

Market Cap $56.3B as of Oct 10, 2026

Price / Sales 2.0x on $27.7B revenue, trailing 12 months to June 30, 2026

Price / Earnings 18.2x on $3.1B net income, trailing 12 months to June 30, 2026

Price / Book 2.8x on $19.9B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 27, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 27, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BKR SEC filings page.

Baker Hughes Company (BKR) reported $27.7B in revenue over the twelve months to Jun 30, 2026, up 0.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BKR FY2025 2026-10-03

Baker Hughes is converting stable sales into more cash while reducing leverage, making balance-sheet improvement the key operating change.

Despite slightly lower revenue, free-cash-flow margin increased from 7.4% to 9.2%, showing improved cash output without top-line expansion. Operating cash flow rose to $3.81B even as net income eased to $2.59B, so the cash improvement was not driven by reported profit growth alone.

The operating margin widened from 9.1% to 11.1% between FY2023 and FY2024, indicating that more revenue reached operating profit as the business expanded. SG&A then declined to $2.39B in FY2025, indicating continued expense restraint despite slightly lower revenue.

Debt-to-equity fell from 0.4x to 0.3x between FY2024 and FY2025, indicating declining leverage. At the same time, current ratio improved to 1.4x and equity reached $18.83B, so the balance-sheet change reflects both better short-term coverage and a larger equity base.

Financial Health Signals

Financial Health Score 63/100

Scored as: Energy peer group

Scored against energy companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Baker Hughes Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Growth

Baker Hughes Company's revenue declined 0.3% year-over-year, from $27.8B to $27.7B. This contraction results in a growth score of 56/100.

Leverage

Baker Hughes Company carries a low D/E ratio of 0.29, meaning only $0.29 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 72/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Baker Hughes Company's current ratio of 1.36 indicates adequate short-term liquidity, earning a score of 53/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Baker Hughes Company has a free cash flow margin of 9.2%, earning a moderate score of 64/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Baker Hughes Company earns a strong 13.7% return on equity (ROE), meaning it generates $14 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 73/100. This is down from 17.6% the prior year.

Piotroski F-Score Partial

6/8

Baker Hughes Company passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.47x

For every $1 of reported earnings, Baker Hughes Company generates $1.47 in operating cash flow ($3.8B OCF vs $2.6B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6.7B

YoY-2.4%

QoQ+2.4%

5Y CAGR+5.6%

10Y CAGR+7.7%

Baker Hughes Company generated $6.7B in revenue in Q2 2026. This represents a decrease of 2.4% from the same quarter a year earlier. Against the prior quarter it is up 2.4%.

Net Income

$681.0M

YoY-2.9%

QoQ-26.8%

Baker Hughes Company reported $681.0M in net income in Q2 2026. This represents a decrease of 2.9% from the same quarter a year earlier. Against the prior quarter it is down 26.8%.

EBITDA

Not reported for Q2 2026.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$1.0B

YoY+400.0%

QoQ+537.2%

5Y CAGR+25.5%

Baker Hughes Company generated $1.0B in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 400.0% from the same quarter a year earlier. Against the prior quarter it is up 537.2%.

Cash & Debt

$15.7B

YoY+409.5%

QoQ+6.5%

5Y CAGR+32.1%

Baker Hughes Company held $15.7B in cash against $15.5B in long-term debt as of Q2 2026.

Shares Outstanding

993M

YoY+0.7%

QoQ+0.1%

Baker Hughes Company had 993M shares outstanding in Q2 2026. This represents an increase of 0.7% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Net Margin

10.1%

YoY0.0pp

QoQ-4.0pp

5Y change+11.4pp

10Y change+10.1pp

Baker Hughes Company's net profit margin was 10.1% in Q2 2026, showing the share of revenue converted to profit. That is unchanged from the same quarter a year earlier. Against the prior quarter it is down 4.0 percentage points.

Return on Equity

3.4%

YoY-0.5pp

QoQ-1.4pp

5Y change+3.9pp

Baker Hughes Company's ROE was 3.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.4 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

R&D Spending

$143.0M

YoY-11.2%

QoQ+7.5%

Baker Hughes Company invested $143.0M in research and development in Q2 2026. This represents a decrease of 11.2% from the same quarter a year earlier. Against the prior quarter it is up 7.5%.

Share Buybacks

YoY-100.0%

Baker Hughes Company repurchased no shares in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier.

Capital Expenditures

$300.0M

YoY-0.3%

QoQ-10.7%

5Y CAGR+11.9%

Baker Hughes Company invested $300.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 0.3% from the same quarter a year earlier. Against the prior quarter it is down 10.7%.

BKR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BKR quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Revenue	$27.7B	$27.7B-0.3%	$27.8B+9.1%	$25.5B+20.6%	$21.2B+3.2%	$20.5B-1.0%	$20.7B-13.1%	$23.8B+4.2%	$22.9B+33.2%	$17.2B+31.3%	$13.1B-21.6%	$16.7B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$9.4B+20.3%	$7.8B-15.7%	$9.3B
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$4.4B+11.2%	$4.0B+31.3%	$3.0B+3.5%	$2.9B-60.5%	$7.4B
R&D Expenses	$569.0M	$600.0M-6.7%	$643.0M-1.2%	$651.0M+17.9%	$552.0M+12.2%	$492.0M-17.3%	$595.0M-13.4%	$687.0M-1.9%	$700.0M+39.7%	$501.0M+42.3%	$352.0M-13.7%	$408.0M
SG&A Expenses	$2.4B	$2.4B-2.9%	$2.5B-5.9%	$2.6B+4.0%	$2.5B+1.6%	$2.5B+2.7%	$2.4B-15.1%	$2.8B+4.9%	$2.7B+6.5%	$2.5B+31.6%	$1.9B-8.9%	$2.1B
Operating Income	N/A	N/A	$3.1B+33.0%	$2.3B+95.5%	$1.2B-9.5%	$1.3B+108.2%	-$16.0B-1587.7%	$1.1B+53.2%	$701.0M+346.8%	-$284.0M-162.1%	$457.0M+431.2%	-$138.0M
EBITDA	N/A	N/A	$4.2B+23.9%	$3.4B+51.6%	$2.2B-7.0%	$2.4B+116.5%	-$14.7B-688.3%	$2.5B+13.9%	$2.2B+167.0%	$819.0M-18.7%	$1.0B+156.9%	$392.0M
Interest Expense	-$269.0M	-$222.0M-12.1%	-$198.0M+8.3%	-$216.0M+14.3%	-$252.0M+15.7%	-$299.0M-13.3%	-$264.0M-11.4%	-$237.0M-6.3%	-$223.0M-70.2%	-$131.0M-28.4%	-$102.0M+15.0%	-$120.0M
Income Tax	$391.0M	$253.0M-1.6%	$257.0M-62.5%	$685.0M+14.2%	$600.0M-20.8%	$758.0M+35.6%	$559.0M+16.0%	$482.0M+86.8%	$258.0M+473.3%	$45.0M-74.0%	$173.0M-63.4%	$473.0M
Net Income	$3.1B	$2.6B-13.1%	$3.0B+53.3%	$1.9B+423.3%	-$601.0M-174.4%	-$219.0M+97.8%	-$9.9B-7865.6%	$128.0M-34.4%	$195.0M+289.3%	-$103.0M	$0	$0
EPS (Basic)	N/A	N/A	$3.00+55.4%	$1.93+416.4%	-$0.61-125.9%	-$0.27+98.2%	-$14.73-6504.3%	$0.23-50.0%	$0.46+291.7%	-$0.24	N/A	N/A
EPS (Diluted)	—	N/A	$2.98+56.0%	$1.91+413.1%	-$0.61-125.9%	-$0.27+98.2%	-$14.73-6504.3%	$0.23-48.9%	$0.45+287.5%	-$0.24	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$6.7B-2.4%	$6.6B+2.5%	$7.4B+0.3%	$7.0B+1.5%	$6.9B-3.2%	$6.4B+0.1%	$7.4B+7.8%	$6.9B+4.0%
R&D Expenses	$143.0M-11.2%	$133.0M-8.9%	$147.0M-9.8%	$146.0M-7.6%	$161.0M+1.9%	$146.0M-11.0%	$163.0M	$158.0M
SG&A Expenses	$569.0M+0.4%	$562.0M-2.6%	$636.0M+8.7%	$607.0M-0.8%	$567.0M-11.8%	$577.0M-6.6%	$585.0M-7.7%	$612.0M-2.4%
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	$665.0M+2.2%	$930.0M+30.3%
EBITDA	N/A	N/A	N/A	N/A	N/A	N/A	$957.0M+3.3%	$1.2B+23.1%
Interest Expense	-$66.0M-22.2%	-$86.0M-68.6%	-$61.0M-10.9%	-$56.0M-1.8%	-$54.0M-14.9%	-$51.0M-24.4%	-$55.0M-22.2%	-$55.0M-12.2%
Income Tax	$210.0M-18.0%	$336.0M+121.1%	-$359.0M+10.0%	$204.0M-13.2%	$256.0M+5.3%	$152.0M-14.6%	-$399.0M-662.0%	$235.0M0.0%
Net Income	$681.0M-2.9%	$930.0M+131.3%	$876.0M-25.7%	$609.0M-20.5%	$701.0M+21.1%	$402.0M-11.6%	$1.2B+168.6%	$766.0M+47.9%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

BKR Balance Sheet

BKR quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Total Assets	$40.9B+6.6%	$38.4B+3.8%	$36.9B+8.1%	$34.2B-3.2%	$35.3B-7.1%	$38.0B-28.8%	$53.4B+1.8%	$52.4B-7.2%	$56.5B+163.2%	$21.5B	N/A
Current Assets	$18.8B+9.4%	$17.2B+5.6%	$16.3B+11.7%	$14.6B-3.1%	$15.1B-8.4%	$16.5B+8.1%	$15.2B+1.7%	$15.0B-18.7%	$18.4B+150.9%	$7.3B	N/A
Cash & Equivalents	$3.7B+10.4%	$3.4B+27.1%	$2.6B+6.4%	$2.5B-35.4%	$3.9B-6.8%	$4.1B+27.2%	$3.2B-12.7%	$3.7B-47.0%	$7.0B+616.6%	$981.0M-31.5%	$1.4B
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$5.0B0.0%	$5.0B-2.7%	$5.1B+11.1%	$4.6B+15.3%	$4.0B-10.0%	$4.4B-4.1%	$4.6B-0.3%	$4.6B+2.5%	$4.5B+42.4%	$3.2B	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$6.1B-0.2%	$6.1B-1.0%	$6.1B+3.5%	$5.9B-0.5%	$6.0B-0.3%	$6.0B-71.1%	$20.7B-0.1%	$20.7B+4.0%	$19.9B+198.3%	$6.7B-2.7%	$6.9B
Total Liabilities	$22.0B+2.7%	$21.5B-0.5%	$21.6B+9.0%	$19.8B-3.4%	$20.5B-18.5%	$25.1B-20.1%	$31.4B-10.1%	$35.0B-17.2%	$42.2B+474.2%	$7.4B	N/A
Current Liabilities	$13.9B+6.8%	$13.0B0.0%	$13.0B+17.3%	$11.1B+21.3%	$9.1B-10.7%	$10.2B+2.1%	$10.0B+11.0%	$9.0B-2.2%	$9.2B+73.3%	$5.3B	N/A
Non-Current Liabilities	$8.2B-3.6%	$8.5B-1.3%	$8.6B-1.4%	$8.7B-23.2%	$11.3B-23.8%	$14.9B-30.5%	$21.4B-17.4%	$26.0B-21.3%	$33.0B+1526.2%	$2.0B	N/A
Long-Term Debt	$5.4B-9.6%	$6.0B+1.7%	$5.9B-1.8%	$6.0B-10.6%	$6.7B-0.8%	$6.7B+7.0%	$6.3B+0.3%	$6.3B-0.4%	$6.3B+16510.5%	$38.0M	N/A
Total Equity	$18.8B+11.5%	$16.9B+9.9%	$15.4B+6.8%	$14.4B-2.9%	$14.8B+15.0%	$12.9B-41.2%	$21.9B+25.6%	$17.5B+22.3%	$14.3B+1.2%	$14.1B-3.0%	$14.5B
Retained Earnings	-$3.3B+44.3%	-$5.8B+33.8%	-$8.8B+18.0%	-$10.8B-5.9%	-$10.2B-2.2%	-$9.9B	$0-100.0%	$25.0M+124.3%	-$103.0M	$0	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$52.6B+35.8%	$50.9B+33.6%	$40.9B+6.6%	$39.2B+4.5%	$38.7B+5.7%	$38.1B+2.6%	$38.4B+3.8%	$37.5B+2.7%
Current Assets	$30.6B+73.6%	$28.6B+69.8%	$18.8B+9.4%	$17.5B+5.8%	$17.6B+10.6%	$16.8B+2.6%	$17.2B+5.6%	$16.6B+2.5%
Cash & Equivalents	$15.7B+409.5%	$14.8B+350.5%	$3.7B+10.4%	$2.7B+1.1%	$3.1B+35.2%	$3.3B+20.6%	$3.4B+27.1%	$2.7B-16.8%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$5.0B-2.8%	$4.9B-5.7%	$5.0B0.0%	$5.0B-4.1%	$5.1B-0.4%	$5.2B-3.3%	$5.0B-2.7%	$5.3B+5.8%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$5.6B-4.1%	$6.0B-1.5%	$6.1B-0.2%	$6.1B-1.9%	$5.8B-5.0%	$6.1B+0.2%	$6.1B-1.0%	$6.2B+2.0%
Total Liabilities	$32.7B+55.5%	$31.6B+49.9%	$22.0B+2.7%	$21.1B-1.2%	$21.0B-0.2%	$21.1B-3.1%	$21.5B-0.5%	$21.3B+0.2%
Current Liabilities	$14.6B+16.7%	$13.4B+6.5%	$13.9B+6.8%	$12.4B-2.8%	$12.5B-0.6%	$12.6B-4.4%	$13.0B0.0%	$12.8B+0.9%
Non-Current Liabilities	$18.1B+112.4%	$18.2B+114.4%	$8.2B-3.6%	$8.6B+1.0%	$8.5B+0.4%	$8.5B-1.1%	$8.5B-1.3%	$8.6B-0.8%
Long-Term Debt	$15.5B+159.4%	$15.4B+158.2%	$5.4B-9.6%	$6.0B+0.1%	$6.0B+1.8%	$6.0B+1.9%	$6.0B+1.7%	$6.0B+2.2%
Total Equity	$19.9B+12.5%	$19.3B+13.3%	$18.8B+11.5%	$18.2B+12.2%	$17.7B+13.6%	$17.0B+10.7%	$16.9B+9.9%	$16.2B+6.2%
Retained Earnings	-$1.6B+65.4%	-$2.3B+57.3%	-$3.3B+44.3%	-$4.1B+41.2%	-$4.7B+39.2%	-$5.4B+35.0%	-$5.8B+33.8%	-$7.0B+24.2%

Not reported in any period shown, so not listed: Accounts Receivable.

BKR Cash Flow Statement

BKR quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Operating Cash Flow	$4.4B	$3.8B+14.3%	$3.3B+8.8%	$3.1B+62.2%	$1.9B-20.5%	$2.4B+82.1%	$1.3B-38.7%	$2.1B+20.7%	$1.8B+320.5%	-$799.0M-405.0%	$262.0M-79.5%	$1.3B
Depreciation & Amortization	N/A	$1.2B+4.6%	$1.1B+4.5%	$1.1B+2.5%	$1.1B-4.0%	$1.1B-16.1%	$1.3B-7.1%	$1.4B-4.6%	$1.5B+34.7%	$1.1B+100.5%	$550.0M+3.8%	$530.0M
Stock-Based Compensation	N/A	$203.0M+0.5%	$202.0M+2.5%	$197.0M-4.8%	$207.0M+1.0%	$205.0M-2.4%	$210.0M	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	$1.3B	$1.3B-0.4%	$1.3B+4.4%	$1.2B+23.8%	$989.0M+15.5%	$856.0M-12.1%	$974.0M-21.5%	$1.2B+24.6%	$995.0M+49.6%	$665.0M+56.8%	$424.0M-30.1%	$607.0M
Free Cash Flow	$3.1B	$2.5B+23.5%	$2.1B+11.8%	$1.8B+104.4%	$899.0M-40.8%	$1.5B+360.0%	$330.0M-62.8%	$886.0M+15.5%	$767.0M+152.4%	-$1.5B-803.7%	-$162.0M-124.2%	$670.0M
Investing Cash Flow	-$574.0M	-$2.0B-101.2%	-$1.0B-24.4%	-$817.0M+47.8%	-$1.6B-237.8%	-$463.0M+25.1%	-$618.0M+40.9%	-$1.0B-80.8%	-$578.0M+86.0%	-$4.1B-773.5%	-$472.0M-1.3%	-$466.0M
Financing Cash Flow	$8.8B	-$1.5B+2.9%	-$1.5B+24.7%	-$2.0B-27.4%	-$1.6B+25.7%	-$2.1B-1052.4%	$225.0M+114.7%	-$1.5B+64.8%	-$4.4B-140.0%	$10.9B+10804.9%	-$102.0M+80.2%	-$515.0M
Dividends Paid	$910.0M	$910.0M+8.9%	$836.0M+6.4%	$786.0M+8.3%	$726.0M+22.6%	$592.0M+21.3%	$488.0M+23.5%	$395.0M+25.4%	$315.0M+103.2%	$155.0M	$0	$0
Share Buybacks	$0	$384.0M-20.7%	$484.0M-10.0%	$538.0M-35.0%	$828.0M+90.8%	$434.0M	$0	$0-100.0%	$387.0M+122.4%	$174.0M	$0	$0

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$1.3B+163.7%	$500.0M-29.5%	$1.7B+39.7%	$929.0M-8.0%	$510.0M+46.6%	$709.0M-9.6%	$1.2B+27.7%	$1.0B+24.7%
Depreciation & Amortization	$333.0M+13.7%	$354.0M+24.2%	$327.0M+12.0%	$282.0M+1.4%	$293.0M+3.5%	$285.0M+0.7%	$292.0M+6.6%	$278.0M+4.1%
Stock-Based Compensation	N/A	$45.0M-10.0%	N/A	N/A	N/A	$50.0M-2.0%	N/A	N/A
Capital Expenditures	$300.0M-0.3%	$336.0M+12.0%	$377.0M+6.8%	$295.0M-1.7%	$301.0M+3.1%	$300.0M-9.9%	$353.0M-0.8%	$300.0M+6.8%
Free Cash Flow	$1.0B+400.0%	$164.0M-59.9%	$1.3B+53.5%	$634.0M-10.7%	$209.0M+273.2%	$409.0M-9.3%	$837.0M+45.3%	$710.0M+34.2%
Investing Cash Flow	-$164.0M+42.7%	$1.0B+434.8%	-$393.0M-81.1%	-$1.1B-292.2%	-$286.0M-9.6%	-$310.0M-15.2%	-$217.0M+30.9%	-$269.0M-202.2%
Financing Cash Flow	-$236.0M+46.7%	$9.5B+1997.0%	-$258.0M-10.3%	-$279.0M+23.4%	-$443.0M+11.8%	-$502.0M-17.6%	-$234.0M+79.9%	-$364.0M-17.0%
Dividends Paid	$228.0M+0.4%	$228.0M-0.4%	$227.0M+9.1%	$227.0M+8.6%	$227.0M+8.6%	$229.0M+9.0%	$208.0M+4.0%	$209.0M+3.5%
Share Buybacks	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%	$196.0M+18.1%	$188.0M+19.0%	$8.0M-97.5%	$152.0M+26.7%

BKR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BKR quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	18.6%+1.2pp	17.4%-0.3pp	17.7%-4.7pp	22.4%-22.0pp	44.5%
Operating Margin	N/A	11.1%+2.0pp	9.1%+3.5pp	5.6%-0.8pp	6.4%+83.6pp	-77.2%-81.7pp	4.5%+1.5pp	3.1%+4.7pp	-1.7%-5.1pp	3.5%+4.3pp	-0.8%
Net Margin	9.3%-1.4pp	10.7%+3.1pp	7.6%+10.5pp	-2.8%-1.8pp	-1.1%+46.9pp	-48.0%-48.6pp	0.5%-0.3pp	0.9%+1.5pp	-0.6%-0.6pp	0.0%0.0pp	0.0%
Return on Equity	13.7%-3.9pp	17.6%+5.0pp	12.6%+16.8pp	-4.2%-2.7pp	-1.5%+75.6pp	-77.1%-77.7pp	0.6%-0.5pp	1.1%+1.8pp	-0.7%-0.7pp	0.0%0.0pp	0.0%
Return on Assets	6.3%-1.4pp	7.8%+2.5pp	5.3%+7.0pp	-1.8%-1.1pp	-0.6%+25.5pp	-26.2%-26.4pp	0.2%-0.1pp	0.4%+0.5pp	-0.2%-0.2pp	0.0%	N/A
Current Ratio	1.360.0x	1.32+0.1x	1.25-0.1x	1.32-0.3x	1.650.0x	1.61+0.1x	1.52-0.1x	1.66-0.3x	2.00+0.6x	1.38	N/A
Debt-to-Equity	0.29-0.1x	0.350.0x	0.380.0x	0.420.0x	0.45-0.1x	0.52+0.2x	0.29-0.1x	0.36-0.1x	0.44+0.4x	0.00	N/A
Asset Turnover	0.680.0x	0.730.0x	0.69+0.1x	0.620.0x	0.580.0x	0.54+0.1x	0.450.0x	0.44+0.1x	0.30-0.3x	0.61	N/A
FCF Margin	9.2%+1.8pp	7.4%+0.2pp	7.2%+3.0pp	4.3%-3.1pp	7.4%+5.8pp	1.6%-2.1pp	3.7%+0.4pp	3.4%+11.9pp	-8.5%-7.3pp	-1.2%-5.3pp	4.0%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	9.0%-0.5pp	13.5%+2.7pp
Net Margin	10.1%0.0pp	14.1%+7.9pp	11.9%-4.1pp	8.7%-2.4pp	10.1%+2.0pp	6.3%-0.8pp	16.0%+9.6pp	11.1%+3.3pp
Return on Equity	3.4%-0.5pp	4.8%+2.5pp	4.7%-2.3pp	3.4%-1.4pp	4.0%+0.2pp	2.4%-0.6pp	7.0%+4.1pp	4.7%+1.3pp
Return on Assets	1.3%-0.5pp	1.8%+0.8pp	2.1%-0.9pp	1.6%-0.5pp	1.8%+0.2pp	1.1%-0.2pp	3.1%+1.9pp	2.0%+0.6pp
Current Ratio	2.09+0.7x	2.13+0.8x	1.360.0x	1.41+0.1x	1.41+0.1x	1.34+0.1x	1.32+0.1x	1.300.0x
Debt-to-Equity	0.78+0.4x	0.80+0.4x	0.29-0.1x	0.330.0x	0.340.0x	0.350.0x	0.350.0x	0.370.0x
Asset Turnover	0.13-0.1x	0.130.0x	0.180.0x	0.180.0x	0.180.0x	0.170.0x	0.190.0x	0.180.0x
FCF Margin	15.5%+12.5pp	2.5%-3.9pp	17.4%+6.0pp	9.0%-1.2pp	3.0%+2.2pp	6.4%-0.7pp	11.4%+2.9pp	10.3%+2.3pp

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Baker Hughes Company BKR	FY2025	$27.7B	$2.6B	9.3%	$56.3B	63/100
SLB Limited SLB	FY2025	$35.7B	$3.4B	9.4%	$72.6B	70/100
Halliburton Company HAL	FY2025	$22.2B	$1.3B	5.8%	$27.1B	62/100
TechnipFMC plc FTI	FY2025	$9.9B	$963.9M	9.7%	$27.3B	70/100
Tenaris S. A. TS	FY2025	$12.0B	$2.0B	16.5%	$28.9B	33/100
NOV Inc. NOV	FY2025	$8.7B	$145.0M	1.7%	$6.8B	59/100

Where Baker Hughes Company Ranks

Frequently Asked Questions

What is Baker Hughes Company's annual revenue?

Baker Hughes Company (BKR) reported $27.7B in total revenue for fiscal year 2025. This represents a -0.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Baker Hughes Company's revenue growing?

Baker Hughes Company (BKR) revenue declined by 0.3% year-over-year, from $27.8B to $27.7B in fiscal year 2025.

Is Baker Hughes Company profitable?

Yes, Baker Hughes Company (BKR) reported a net income of $2.6B in fiscal year 2025, with a net profit margin of 9.3%.

How much debt does Baker Hughes Company have?

As of fiscal year 2025, Baker Hughes Company (BKR) had $3.7B in cash and equivalents against $5.4B in long-term debt.

What is Baker Hughes Company's net profit margin?

Baker Hughes Company (BKR) had a net profit margin of 9.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Baker Hughes Company's return on equity (ROE)?

Baker Hughes Company (BKR) has a return on equity of 13.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Baker Hughes Company's free cash flow?

Baker Hughes Company (BKR) generated $2.5B in free cash flow during fiscal year 2025. This represents a 23.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Baker Hughes Company's operating cash flow?

Baker Hughes Company (BKR) generated $3.8B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Baker Hughes Company's total assets?

Baker Hughes Company (BKR) had $40.9B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Baker Hughes Company's capital expenditures?

Baker Hughes Company (BKR) invested $1.3B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Baker Hughes Company spend on research and development?

Baker Hughes Company (BKR) invested $600.0M in research and development during fiscal year 2025.

Does Baker Hughes Company buy back shares?

Yes, Baker Hughes Company (BKR) spent $384.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Baker Hughes Company have outstanding?

Baker Hughes Company (BKR) had 988M shares outstanding as of fiscal year 2025.

What is Baker Hughes Company's current ratio?

Baker Hughes Company (BKR) had a current ratio of 1.36 as of fiscal year 2025, which is considered adequate.

What is Baker Hughes Company's debt-to-equity ratio?

Baker Hughes Company (BKR) had a debt-to-equity ratio of 0.29 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Baker Hughes Company's return on assets (ROA)?

Baker Hughes Company (BKR) had a return on assets of 6.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Baker Hughes Company's P/E ratio?

Baker Hughes Company (BKR) trades at 18.2x earnings, its market capitalization divided by net income of $3.1B net income, trailing 12 months to June 30, 2026. The market capitalization is $56.3B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Baker Hughes Company's price-to-sales ratio?

Baker Hughes Company (BKR) trades at 2.0x sales, its market capitalization divided by revenue of $27.7B revenue, trailing 12 months to June 30, 2026. The market capitalization is $56.3B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Baker Hughes Company's Piotroski F-Score?

Baker Hughes Company (BKR) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Baker Hughes Company's earnings high quality?

Baker Hughes Company (BKR) has an earnings quality ratio of 1.47x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Baker Hughes Company?

Baker Hughes Company (BKR) scores 63 out of 100 on our Financial Health Score, indicating moderate standing within its energy companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.